Clinical predictors of response to immunomodulators for multiple sclerosis.


OBJECTIVES To determine, based on clinical criteria, the proportion of multiple sclerosis (MS) patients responsive to immunomodulators (RI) and nonresponsive to immunomodulators (NRI), and to ascertain whether clinical and epidemiological data differs between RI and NRI patient groups. METHODS Patients were assessed on rate of exarcerbations per year, for… (More)